GlassScriptPhysician profile
William M Brown
NPI 1366404154
$1,728.38
in general payments reported to CMS, 2019-2025
22 companies · $23.80 in 2025
The $23.80 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,056 · 2020: $281 · 2021: $175 · 2023: $15.52 · 2024: $176 · 2025: $23.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $174 · Education: $42.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $173.77 |
| Education | $42.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $237.79 | 2019-2021 | |
| Amarin Pharma, INC. | $214.25 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $208.95 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $159.16 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $120.78 | 2019-2021 | |
| Siemens Medical Solutions USA, INC. | $105.64 | 2023-2025 | Atellica Im 1300 Analyzer, Atellica Ch 930 Analyzer |
| Pfizer INC. | $85.31 | 2019 | |
| Sanofi-Aventis U.S. LLC | $84.53 | 2019 | |
| United Orthopedics LLC | $68.13 | 2024 | |
| Lundbeck LLC | $55.94 | 2019 | |
| United Therapeutics Corporation | $52.93 | 2020 | |
| Boston Scientific Corporation | $51.80 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $51.10 | 2019-2021 | |
| Medtronic, INC. | $42.00 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $37.04 | 2019-2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $31.96 | 2019 | |
| Arbor Pharmaceuticals, INC. | $28.12 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.91 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $19.88 | 2020 | |
| Akcea Therapeutics, INC. | $18.76 | 2019 | |
| Chiesi USA, INC. | $14.69 | 2019 | |
| Esperion Therapeutics, INC. | $12.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.